Why is Makers Laboratories Ltd falling/rising?

Recent Price Movement and Market Context

Makers Laboratories Ltd has been trading close to its 52-week low, currently just 3.63% above the lowest price of ₹109 recorded over the past year. The stock has underperformed its sector by 1.01% today and has experienced a consecutive two-day decline, resulting in a cumulative loss of 6.57% over this short period. Notably, the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling persistent bearish momentum.

Investor participation has seen a significant spike, with delivery volumes on 22 Dec rising by over 1296% compared to the five-day average. Despite this surge in trading activity, the stock’s liquidity remains adequate for sizeable trades, although this has not translated into price support.

Long-Term Underperformance Compared to Benchmarks

Over multiple time horizons, Makers Laboratories Ltd has consistently lagged behind the broader market. In the past week, the stock declined by 5.79%, while the Sensex gained 1.00%. The one-month performance shows a 13.00% loss against a modest 0.34% gain in the Sensex. Year-to-date, the stock has plummeted 37.53%, in stark contrast to the Sensex’s 9.45% rise. Over the last year, the stock’s return was negative 34.34%, whereas the Sensex appreciated by 8.89%. Even over three and five years, Makers Laboratories Ltd has underperformed significantly, with losses of 3.42% and 53.72% respectively, compared to Sensex gains of 42.91% and 84.15%.

Fundamental Weaknesses Weighing on Investor Sentiment

The company’s financial health has been a major factor behind the stock’s decline. Makers Laboratories Ltd has exhibited a negative compound annual growth rate (CAGR) of 19.06% in operating profits over the last five years, indicating deteriorating earnings power. Its average return on equity (ROE) stands at a low 2.20%, reflecting limited profitability relative to shareholders’ funds. The most recent quarterly results, reported in September 2025, were flat, offering little encouragement to investors seeking growth.

Moreover, the stock’s valuation appears stretched despite weak fundamentals. With an ROE close to zero, the company’s price-to-book value ratio is 0.9, suggesting it trades at a premium relative to its peers’ historical valuations. This disconnect between valuation and earnings performance has likely contributed to investor caution.

Profitability has also sharply declined, with profits falling by over 100% in the past year, a stark indicator of operational challenges. This has translated into sustained negative returns for shareholders, with the stock underperforming the BSE500 index across multiple periods including the last three years, one year, and three months.

Conclusion: Why the Stock Is Falling

The decline in Makers Laboratories Ltd’s share price is primarily attributable to its weak long-term financial performance, deteriorating profitability, and valuation concerns. Despite increased trading volumes, the stock remains close to its 52-week low and continues to underperform market benchmarks significantly. Investors appear wary of the company’s flat recent results and negative profit growth, which have undermined confidence in its growth prospects. The stock’s premium valuation relative to its peers, despite poor returns and low ROE, further dampens investor enthusiasm.

In summary, Makers Laboratories Ltd’s share price is falling due to a combination of fundamental weaknesses, sustained underperformance against the Sensex and sector indices, and a lack of positive catalysts to reverse the negative trend.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →